Ticagrelor-d7
Product Specifications
CAS Number
1265911-55-4
Target
P2Y Receptor
Related Pathways
Neuroscience, GPCR/G Protein
Bioactivity
Ticagrelor-d7 is a deuterated compound of Ticagrelor. Ticagrelor has a CAS number of 274693-27-5. Ticagrelor, produced by AstraZeneca, is an inhibitor of platelet aggregation. Unlike clopidogrel, ticagrelor is not a prodrug required metabolic activation. The drug was approved for use in the European Union by the European Commission on December 3, 2010, and by the US FDA on July 20, 2011. Its trade names are Brilinta (US), Brilique (EU) and Possia (EU) .
Smiles
N1C2C(N[C@@H]3C[C@H]3C3C=C(F)C(F)=CC=3)=NC(SC([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])=NC=2N([C@H]2[C@H](O)[C@H](O)[C@@H](OCCO)C2)N=1
Molecular Formula
C23H21D7F2N6O4S
Molecular Weight
529.61
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15128402 1 Vial
Lentiviral mouse Tuba3a shRNA (UAS) - Lentiviral mouse Tuba3a shRNA (UAS, iRFP) (25)
Sign In for Pricing
View Details 
032629-ML650 100 µL
BUD13, CT (BUD13, BUD13 homolog) (MaxLight 650) discontinued
Sign In for Pricing
View Details